healthy

AS the UK waves goodbye to summer, experts are urging people to take extra precautions to stay healthy.

As winter illnesses start to circulate, one virus parents are being asked to be especially wary of is RSV – as new evidence shows it can be just as risky to healthy babies as those born premature of with underlying health conditions.

2

RSV, which stands for respiratory syncytial virus, is a common cause of respiratory infections in young children and accounts for around 245,000 hospital admissions annually in Europe. 

In some cases, it can lead to more severe respiratory issues like bronchiolitis and pneumonia, which can lead to hospitalisation, the need for oxygen or mechanical ventilation, and even death.

Researchers have now analysed data from more than 2.3 million children born in Sweden between 2001 and 2022 to find out who is at greatest risk of suffering serious complications or dying from an RSV infection

Almost all children will get RSV at least once before they’re two years old.

Premature babies and children with chronic diseases are known to be at increased risk of developing severe illness when infected with the virus.

And children under three months of age are also particularly vulnerable – although it hasn’t been entirely clear how common severe disease is among previously healthy children. 

As part of their findings, scientists from Karolinska Institutet in Sweden found the largest group among the children who required intensive care or were hospitalised for a long period of time were under three months of age, previously healthy and born at full term.

“When shaping treatment strategies, it is important to take into account that even healthy infants can be severely affected by RSV,” said the study’s first author, Giulia Dallagiacoma, a physician and doctoral student at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet.

“The good news is that there is now preventive treatment that can be given to newborns, and a vaccine that can be given to pregnant women.”

The NHS RSV vaccine programme was launched in England on September 1, 2024 offering protection to pregnant women from 28 weeks gestation to protect their baby and to older adults aged 75 to 79.

Several factors were linked to an increased risk of needing intensive care or dying by the researchers.

Children who were born in the winter, or had siblings aged 0–3 years or a twin, had approximately a threefold increased risk, while children who were small at birth had an almost fourfold raised risk.

Children with underlying medical conditions had more than a fourfold increased risk of severe illness or death.

“We know that several underlying diseases increase the risk of severe RSV infection, and it is these children who have so far been targeted for protection with the preventive treatment that has been available,” said the study’s last author, Samuel Rhedin, resident physician at Sachs’ Children and Youth Hospital and associate professor at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet.

“However, the study highlights that a large proportion of children who require intensive care due to their RSV infection were previously healthy.

“Now that better preventive medicines are available, it is therefore positive that the definition of risk groups is being broadened to offer protection during the RSV season to previously healthy infants as well.”

In the UK, if you’re pregnant, you should be offered the RSV vaccine around the time of your 28-week antenatal appointment.

If you’re aged 75 to 79 (or turned 80 after 1 September 2024) contact your GP surgery to book your RSV vaccination.

2

Spotting RSV symptoms is important to help prevent serious complications.

Most people who get an RSV infection will only get cold-like symptoms, according to the NHS, including the five following signs:

• a runny or blocked nose
• a cough
• sneezing
• tiredness
• a high temperature – signs include your back or chest feeling hotter than usual, sweatiness and shivering (chills)

Babies with RSV may also be irritable and feed less than usual.

But if RSV leads to a more serious infection (such as pneumonia or bronchiolitis) it may also cause a worsening cough, shortness of breath, faster breathing, difficulty feeding in babies, wheezing, and confusion in older adults.

It’s important to note cold-like symptoms are very common in babies and children and aren’t usually a sign of anything serious.

They should get better within a few days.

There’s no specific treatment for an RSV infection as it often gets better on its own in one or two weeks.

If you or your child have mild RSV symptoms, there are some things you can do to help ease symptoms at home, including taking paracetamol or ibuprofen if you have a high temperature and are uncomfortable (giving children’s paracetamol or children’s ibuprofen to your child) and drinking lots of fluids.

But children and adults who get a more serious infection may need to be treated in hospital.

IF you use a hair dryer, or heated styling tools, you should also be using heat protectant to keep your hair healthy.

Without it, strands will become dry, brittle and harder to manage.

4

Try these three . . . 

BUDGET

E45 Protection Lip Balm SPF30, £7.99 for 10ml, boots.com

4

Arkive The Prologue hair primer, £14 for 200ml, boots.com

You really can’t go wrong with this product.

Not only does it protect hair from heat, it also de-tangles, adds shine, reduces frizz and smells delicious, thanks to the rhubarb, tomato leaf, honeysuckle and vetiver.

So it doubles up as a hair perfume.

It makes my hair feel like silk, and I really notice on the days I don’t use it, which is always the sign of a brilliant product.

It’s also nearly impossible to apply too much, as it doesn’t weigh hair down or leave it looking greasy.

MID-RANGE

Ghd Bodyguard heat protect spray, £23.95 for 120ml, boots.com

4

Ghd Bodyguard heat protect spray, £23.95 for 120ml, boots.com

As the original heat-straightener brand, it will come as no surprise that ghd knows how to protect hair from styling.

This spray isn’t at all sticky and does not leave a residue behind, despite conditioning ingredients such as castor oil and glycerin.

It also helps maintain my style for longer, so curls don’t drop out by the end of the day, which is usually the case.

Plus, it smells like a fancy hair salon, so every time I use it I feel like I have had a professional treatment.

LUXURY

Dyson Omega leave-in conditioning spray, £59.99 for 165ml, dyson.co.uk

4

Dyson Omega leave-in conditioning spray, £59.99 for 165ml, dyson.co.uk

This is the newest heat protectant in my arsenal, and its almost milky formula is thicker than the others.

That is great for dull, brittle lengths or hair that gets dry between washes, as it immediately softens strands.

I have very fine hair, and if I apply too much to my roots it can make them feel dirty, so that’s something to be aware of.

But as long as I keep the spray away from my scalp, it’s not an issue.

This one feels super luxe, and is refillable, so better for the planet too.

PICK OF THE WEEK

THIS week, I had a Charlotte Tilbury makeover and afterwards, couldn’t stop looking at my skin in the mirror.

The redness across my cheeks and around my nose had disappeared, my pores were blurred and, best of all, I was glowy without looking greasy.

It was all down to the new Charlotte Tilbury airbrush flawless foundation, £39, which promises 24-hour wear.

For details, see charlottetilbury.co.uk.

Blue Zones are five diverse regions where people live longer and stay healthy into their 90s and 100s. Their secrets? Mostly plant-based diets, daily natural movement, strong social ties, and a clear sense of purpose. These simple, sustainable habits keep people active and resilient. As the modern world faces chronic illness and ageing populations, the Blue Zones offer practical lessons on how we might live longer, healthier, and more fulfilling lives.

Presenter: Stefanie Dekker

Guests:
Anna Katsas – Videographer and content creator
Paola Demurtas – Longevity guide
Luigi Fontana – Director, Charles Perkins Centre Clinic

The Dodgers’ biggest question this season is an eerily familiar one.

Will their pitching ever get back to full (or at least, significantly improved) health? And will it be as productive as expected if or when that happens?

To this point, the team remains confident on both fronts.

Injured starters Tyler Glasnow, Blake Snell and Roki Sasaki are all in throwing progressions. Two-way star Shohei Ohtani is continuing to build up his arm through weekly live batting practices, and Emmet Sheehan is on a rehab assignment with triple-A Oklahoma City. And a whole litany of relievers are also expected back at some point, with Kirby Yates and Michael Kopech likely to return this weekend, and Blake Treinen and Brusdar Graterol possibilities over the coming couple of months.

Still, as this last week has epitomized, there is an ever-present lack of certainty hanging over the state of the staff as well, with the recovery of any injured pitcher seemingly liable to shift at any moment.

“I’m very confident we’re going to get them all back,” manager Dave Roberts said Wednesday. “I just don’t know when.”

This week, Glasnow became the latest example of that unpredictable dynamic.

On Monday, Roberts offered a seemingly troublesome update on the oft-injured right-hander. After Glasnow had thrown one bullpen session a week and a half earlier, a bout of back tightness had kept him from throwing off a mound again since.

“There was one ‘pen and, then [his] body didn’t respond,” Roberts said. “So we’re trying to figure out when we can ramp him back up.”

On Tuesday, however, Glasnow presented a more optimistic version of events. Yes, his back became “a little tight” after his initial bullpen session, he said. But he described the resulting pause in his throwing progression as nothing more than a “precaution,” adding that he plans to resume throwing bullpens in the coming week.

“I feel totally fine, totally normal,” said Glasnow, who initially went on the injured list in April because of shoulder inflammation. “My shoulder’s totally fine. That issue, I haven’t felt since I started throwing. It was fine. [The back tightness] really was just, I think, a precaution. I felt totally fine. I’m good to go.”

During his time on the IL, Glasnow believes he found a middle ground between the pitching mechanics he had last year (when his season ended early with elbow tendinitis) and the changes he made over the winter (which he felt contributed to his more recent shoulder issue).

Dodgers pitcher Roki Sasaki watches a game against the Arizona Diamondbacks from the dugout at Dodger Stadium on May 21.

(Gina Ferazzi / Los Angeles Times)

“Trying to meld a best-of-both worlds situation,” he said. “But right now, I feel really, really good mechanics-wise, to just be athletic and throw. It’s enabled me to just be myself more now.”

And though he is still weeks, if not a month or more, away from being activated, Glasnow said he’s confident about having enough time over the second half of the season to rediscover a rhythm ahead of the playoffs.

“I’m trying to get back as soon as I can,” Glasnow said. “But we’re on the same wavelength of, ‘Let’s get you back out as healthy as possible as soon as possible, in a healthy way.’”

Snell, who has also been out since early April because of shoulder trouble, has endured his own stop-and-start recovery process.

After first going on the injured list two starts into the season — because of shoulder pain that he later said had been bothering him since spring training — Snell started to ramp up a few weeks later, progressing to a bullpen session on April 19.

His shoulder, however, didn’t respond well in the days following that step. Thus, he was shut down from throwing again, and received an injection to help alleviate his lingering discomfort.

Since then, Snell has been on a more methodical throwing plan. Recently, his shoulder has finally started to feel normal. And, like Glasnow, he is hoping to begin throwing bullpens once more over the next week.

“I can’t wait [to get back],” Snell told AM 570 last weekend. “Having to wait, it sucks. It’s a long process. But I’m gonna go slow. I’m gonna make sure I’m ready. So when I start pitching, I can get going and do my thing.”

This remains the Dodgers’ company line with most of their injured arms — the team wanting to purposely take their progressions slowly in the short term, to ensure they are available in the long run later this year.

“As far as return to play, there’s certainly a cautiousness to it,” Roberts said. “Because as you start getting into the middle of the year, then any setback could be detrimental for the rest of the season.”

In the meantime, uncertainty on the mound — where the Dodgers currently rank 22nd in the majors with a 4.10 team ERA — will continue to loom.

There is always the threat of setbacks; like what happened with Evan Phillips, who underwent season-ending Tommy John surgery Wednesday for an injury that was initially expected to sideline him for only two weeks.

And even once pitchers do come back, their levels of performance are subject to variance. That’s been the case recently with Kopech, who struggled so much during a rehab stint in Oklahoma City (where he gave up 11 runs and 11 walks in 6 ⅓ innings) that the Dodgers had him throw a live batting practice session in front of their big league coaching staff Wednesday to help him work through some mechanical adjustments.

“The stuff was good,” Roberts said of Kopech, out since the start of the year because of a shoulder impingement. “Just curious to see what the pitching guys and the training staff feel, and what he thinks of how he felt today. And we’ll kind of move forward after that.”

Yates, who has not required a rehab stint recovering from a hamstring strain, also threw live BP on Wednesday.

“We’ll see how they feel tomorrow,” Roberts said. “And then I think we’ll have a much better decision on this weekend for both guys.”

The good news for the Dodgers is that they do have depth. They don’t need every one of their injured pitchers to return to health and previous form. Even if only half of the arms currently on the IL get back to where they were before, they could still have a pitching staff capable of contending for another World Series title.

Because of that, it seems unlikely they’ll make overly aggressive moves on the trade market leading up to the July 31 deadline. They could use another right-handed reliever to replace Phillips but might be wary of a high-cost splash for a front-line starter (especially after doling out more than half a billion dollars the last two winters to Glasnow, Snell and Yoshinobu Yamamoto).

For now, they continue to trust that pitchers such as Snell, Glasnow and Ohtani will be impact contributors for the stretch run of the season. They are confident that Sasaki (who has continued regular catch play while battling his own shoulder issue), Sheehan and Graterol will give them more pitching coverage as well.

But until then, they will nonetheless face a precariously familiar situation: hoping enough injured pitchers are able to regain health over the course of the season, and that more unforeseen setbacks won’t continue to leave them shorthanded on the mound.

“I think we’re very confident that we’re going to get the guys we’re talking about back,” Roberts said. “Then once we get them back, we got to make sure we keep them back too.”

WASHINGTON, D.C. — Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.

Top officials for the Food and Drug Administration laid out new requirements for yearly updates to COVID shots, saying they’d continue to use a streamlined approach that would make vaccines available to adults 65 and older as well as children and younger adults with at least one health problem that puts them at higher risk.

But the FDA framework urges companies conduct large, lengthy studies before tweaked vaccines can be approved for healthier people. In a framework published Tuesday in the New England Journal of Medicine, agency officials said the approach still could keep annual vaccinations available for between 100 million and 200 million adults.

The upcoming changes raise questions about people who may still want a fall COVID-19 shot but don’t clearly fall into one of the categories.

“Is the pharmacist going to determine if you’re in a high-risk group?” asked Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia. “The only thing that can come of this will make vaccines less insurable and less available.”

The framework, published in the New England Journal of Medicine, is the culmination of a series of recent steps scrutinizing the use of COVID shots and raising major questions about the broader availability of vaccines under President Trump.

For years, federal health officials have told most Americans to expect annual updates to COVID-19 vaccines, similar to the annual flu shot. Just like with flu vaccines, until now the FDA has approved updated COVID shots when manufacturers provide evidence that they spark just as much immunity protection as the previous year’s version.

But FDA’s new guidance appears to be the end of that approach under Health and Human Services Secretary Robert F. Kennedy, who has filled the FDA and other health agencies with outspoken critics of the government’s handling of COVID shots, particularly their recommendation for young, healthy adults and children.

Tuesday’s update, written by FDA Commissioner Marty Makary and FDA vaccine chief Vinay Prasad, criticized the United States’ “one-size-fits-all” approach and states that the U.S. has been “the most aggressive” in recommending COVID boosters, when compared with European countries.

“We simply don’t know whether a healthy 52-year-old woman with a normal BMI who has had COVID-19 three times and has received six previous doses of a COVID-19 vaccine will benefit from the seventh dose,” they wrote.

Outside experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or whether they should be recommended for people at increased risk. An influential panel of advisors to the Centers for Disease Control and Prevention is set to debate that question next month.

The FDA framework announced Tuesday appears to usurp that advisory panel’s job, Offit said. He added that CDC studies have made clear that booster doses do offer protection against mild to moderate illness for four to six months after the shot even in healthy people.

Perrone and Neergaard write for the Associated Press. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

BRITAIN’S most unhealthy high street sandwiches have now been revealed.

Brits will be shocked to know that most of their favourite lunchtime meal deals have more saturated fat and sugar than fast food and desserts.

7

7

7

Most of them also have more calories than McDonald’s cheeseburgers and a bar of DairyMilk chocolate.

Leading the list of unhealthy sandwiches, Pret’s Posh Cheddar & Pickle Baguette sandwich contains a whopping 643 calories.

That is more calories than two McDonald’s cheeseburgers combined, which come at 295 calories each.

Even a Big Mac has almost 150 fewer calories than Pret’s flagship lunchtime meal.

Meanewhile, Waitrose‘s No1 The Perfect Ploughman’s Cornish Cheddar Sandwich comes 13.1g of saturated fat – making it one of the unhealthiest items on the list.

This is again more than two McDonald’s Cheeseburgers combined, which come with just 5.4g of fat each, according to a DailyMail analysis.

Next comes M&S’s Farmhouse Cheddar Cheese Ploughman’s sandwich with 11.3g of saturated fat.

To give some context, a Big Mac burger has just 8.8g of fat.

Both these sandwiches contain more than half of the NHS‘s daily saturated fat limit for women, which is 20g.

When it came to unhealthy sugar content, Sainsbury’s Brie Bacon & Chilli Chutney Sandwich topped the charts with 19.7g sugar.

To put that into perspective, one would need to have two KitKat chocolate bars with 10.3g of sugar in each to beat the Sainsbury’s sandwich.

M&S’s All Day Breakfast Sandwich – a popular choice of meal on the go – has almost 10.1g of sugar.

That’s slightly less than a Krispy Kreme Original Glazed Doughnut that comes with 12g of sugar.

NHS recommends that adults only consume a maximum of 30g of sugar each day to lead a healthy life.

Most of the sandwiches sold on Britain’s high streets are also far saltier than fast food.

For instance, Pret’s Ham & Grevé Baguette contained 3.85g of salt, making it saltier than four large portions of McDonald’s fries (0.82g of salt each).

And surprisingly, even M&S’s Farmhouse Cheddar Cheese Ploughman contained 1.78g – slightly more than two large McDonald’s fries.

Adults are advised to consume less than 6g of salt per day, according to the NHS.

7

7

7

But as most of the supermarket sandwiches are unhealthy options for lunch, Brits can choose to swap them for healthier meals.

For example, a Cheese Ploughman’s sandwich from Boots comes at just 429 calories, making it the healthiest option so far.

And if you feel fancy, you can also try Itsu’s King Prawn Rice Box salad, which comes at just 407 calories.

It’s a filling option thanks to wholegrain brown rice, veggies, prawns and seeds.

Meanwhile, a Tuna Melt Panini from Starbucks packs in an impressive 28g of protein and has just 443 calories.

But if you are really conscious about your health and want to keep things below 400 calories, then Greggs‘ Pesto and Mozzarella Pasta can be your saviour.

This tasty option from Greggs is just  375 calories, even though its packed with cheese.

7